InnoSkel Targets Rapid UK Patient Access For Gene Therapy
INS-101 Is Intended For Rare Bone Disorder
The number of “innovation passports” handed out by the UK Medicines and Healthcare products Regulatory Agency is growing as more companies seek to take advantage of the tools and flexibilities available under the ILAP. InnoSkel is one such company.
